SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.28 CNY | -0.69% |
|
-5.32% | -41.43% |
EPS & Dividend: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 1.214 | 1.23 | 1.379 | 2.571 | 3.836 | 4.407 |
| Distribution rate | - | - | - | - | - | - |
| Reference price 2 | 69.80 | 63.82 | 130.23 | 76.28 | 76.28 | 76.28 |
| Nbr of stocks (in thousands) | 161,372 | 173,568 | 174,425 | 174,425 | - | - |
| Announcement Date | 4/19/22 | 4/19/23 | 4/18/24 | - | - | - |
1CNY in Million2CNY
Estimates
Past dividends: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| 2024-05-21 | Final Payment 3 CNY |
| 2023-09-21 | Interim Payment 1 CNY |
| 2023-05-21 | Final Payment 1 CNY |
| 2022-09-22 | Interim Payment 0.5 CNY |
| 2022-05-19 | Final Payment 0.4 CNY |
| 2021-09-28 | Interim Payment 0.25 CNY |
| 2021-05-20 | Annual 0.25 CNY |
| 2020-05-20 | Annual 0.125 CNY |
| 2019-06-10 | Annual 0.25 CNY |
| 2018-05-31 | Annual 0.25 CNY |
| 2017-06-20 | Annual 0.125 CNY |
Upcoming events: Shenyang Xingqi Pharmaceutical Co.,Ltd.
| 2024-10-23 | Q3 2024 Earnings Release (Projected) |
| 2025-04-17 | Q4 2024 Earnings Release (Projected) |
| 2025-04-24 | Q1 2025 Earnings Release (Projected) |
| 2025-08-27 | Q2 2025 Earnings Release (Projected) |
| Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
|---|---|---|---|---|---|---|
| +1.36% | +1.52% | 24.7x | 2.558 | 3.77x | ||
| +1.81% | +1.89% | 24.95x | 2.000 | 2.8x | ||
| +0.35% | +0.35% | 60.04x | 4.332 | 4.34x | ||
| -.--% | -.--% | 109.64x | 21.68 | 14.55x | ||
| +0.65% | +0.97% | 34.62x | 2.924 | 6.21x | ||
| +17.58% | +20.02% | 11.38x | 1.058 | - | ||
| - | - | 107.17x | - | - | ||
| - | - | - | - | - | ||
| +0.74% | +0.89% | 17.45x | 2.106 | - | ||
| Average | +3.21% | +3.66% | 48.75x | 5.24 | 6.34x | |
| Weighted average by Cap. | +1.53% | +1.71% | 32.35x | 3.58 | 4.33x |
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Estimates Revisions:
More analyst reviews
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition